Early research (Phase 1)Study completedNCT01718899What this trial is testingPhase 1/2a Study of Cancer Vaccine to Treat Smoldering Multiple MyelomaWho this might be right forSmoldering Multiple Myeloma OncoPep, Inc. 22
Not applicableLooking for participantsNCT05283993What this trial is testingA Cohort Study of Plasma Cell Disorders (PCDs) in PKUFHWho this might be right forMultiple MyelomaAmyloidosisCryoglobulinemia+9 more Peking University First Hospital 2,000
Not applicableLooking for participantsNCT05312255What this trial is testingNon-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple MyelomaWho this might be right forPlasma Cell MyelomaRecurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma+1 more Roswell Park Cancer Institute 175
Testing effectiveness (Phase 2)Ended earlyNCT00216151What this trial is testingZoledronic Acid in the Management of Patients With Asymptomatic/Early Stage Multiple MyelomaWho this might be right forMultiple Myeloma Hoosier Cancer Research Network 3
Not applicableLooking for participantsNCT07069751What this trial is testingA Prospective Multicenter Study of the Effects of Plant-based Diets on Gut Microbiome and Derived Metabolites in Patients Affected by Smoldering Multiple MyelomaWho this might be right forSmoldering Multiple Myeloma (SMM) Ciceri Fabio 62
Testing effectiveness (Phase 2)Study completedNCT02316106What this trial is testingEvaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple MyelomaWho this might be right forMultiple Myeloma Janssen Research & Development, LLC 123
Not applicableStudy completedNCT00900263What this trial is testingS0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or PlasmacytomaWho this might be right forMultiple MyelomaPlasma Cell MyelomaPrecancerous Condition SWOG Cancer Research Network 375
Post-approval studies (Phase 4)Study completedNCT01087008What this trial is testingZoledronic Acid in Patients With Multiple Myeloma and Asymptomatic Biochemical RelapseWho this might be right forMultiple Myeloma PETHEMA Foundation 103
Testing effectiveness (Phase 2)Study completedNCT01302886What this trial is testingStudy of BHQ880 in Patients With High Risk Smoldering Multiple MyelomaWho this might be right forSmoldering Multiple Myeloma Novartis Pharmaceuticals 41
Testing effectiveness (Phase 2)Study completedNCT04731844What this trial is testingCurcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate CancerWho this might be right forProstate CancerMultiple MyelomaSmoldering Multiple Myeloma (SMM)+1 more University of Rochester 30
Testing effectiveness (Phase 2)Ended earlyNCT00983346What this trial is testingEffect of Low Dose Bortezomib on Bone Formation in Smoldering Myeloma PatientsWho this might be right forCancerMyelomaMultiple Myeloma University of Utah 17
Testing effectiveness (Phase 2)Ended earlyNCT01096810What this trial is testingStudy of TBL 12 Sea Cucumber Extract for Patients With Untreated Asymptomatic MyelomaWho this might be right forMultiple Myeloma Jagannath, Sundar, M.D. 20
Not applicableLooking for participantsNCT05640843What this trial is testingA Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)Who this might be right forMonoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple Myeloma Memorial Sloan Kettering Cancer Center 180
Not applicableActive Not RecruitingNCT05831358What this trial is testingEarly Detection of Multiple Myeloma to Fight Cancer Disparities: A Screening and Patient Navigation ProgramWho this might be right forMultiple MyelomaMonoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple Myeloma Case Comprehensive Cancer Center 201
Not applicableActive Not RecruitingNCT04023747What this trial is testingOxford Pre-cancerous Lymphoproliferative Disorders StudyWho this might be right forPre-cancerous Lymphoproliferative Disorders University of Oxford 574
Not applicableLooking for participantsNCT05136807What this trial is testingQuality of Life in Patients With Asymptomatic Monoclonal GammopathiesWho this might be right forMonoclonal Gammopathy of Undetermined SignificanceSmoldering Plasma Cell Myeloma M.D. Anderson Cancer Center 400
Testing effectiveness (Phase 2)Active Not RecruitingNCT04775550What this trial is testingDARA RVD For High Risk SMMWho this might be right forHigh-risk Smoldering Multiple MyelomaMultiple Myeloma Omar Nadeem, MD 61
Testing effectiveness (Phase 2)Active Not RecruitingNCT04850846What this trial is testingInvestigation of Metformin for the Prevention of Progression of Precursor Multiple MyelomaWho this might be right forMonoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple Myeloma Dana-Farber Cancer Institute 60